Search

everythinglearnresearchcommunity

for

Search:↓

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Using finasteride with TIP extends time off period for prostate cancer patients.

CEC levels may be a useful marker for predicting prostate cancer progression.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Gene variation affects prostate issues and hair loss.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.